相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Informing Patients: Translating the NCCN Guidelines
Joan S. McClure
Journal of the National Comprehensive Cancer Network (2017)
NCCN Molecular Testing White Paper: Effectiveness, Efficiency, and Reimbursement
Paul F. Engstrom et al.
Journal of the National Comprehensive Cancer Network (2017)
Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer
L. C. Collins et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort
Serena Masciari et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study
Saroj Niraula et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Sarcomas in TP53 Germline Mutation Carriers A Review of the IARC TP53 Database
Simona Ognjanovic et al.
CANCER (2012)
Early onset HER2-positive breast cancer is associated with germline TP53 mutations
Amal Melhem-Bertrandt et al.
CANCER (2012)
Blockade of the HER Family of Receptors in the Treatment of HER2-Positive Metastatic Breast Cancer
Jasgit C. Sachdev et al.
CLINICAL BREAST CANCER (2012)
Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer
Jin Ha Lee et al.
DIGESTIVE AND LIVER DISEASE (2012)
Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets
Gunnel Hallden et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Routine TP53 testing for breast cancer under age 30: ready for prime time?
Jeanna M. McCuaig et al.
FAMILIAL CANCER (2012)
TP53 Germline Mutations in Adult Patients with Adrenocortical Carcinoma
Leonie J. M. Herrmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Advances in the Management of HER2-positive Advanced Gastric and Gastroesophageal Junction Cancer
Yung-Jue Bang
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Targeting Mutant p53 in Human Tumors
Brian D. Lehmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
Soren Lehmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early-Stage Breast Cancer in a Young Woman With Li-Fraumeni Syndrome
Eve Henry et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia
S. Pospisilova et al.
LEUKEMIA (2012)
Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: The Children's Hospital Los Angeles (CHLA) experience, 1991-2010
Alexa E. Gozali et al.
PEDIATRIC BLOOD & CANCER (2012)
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium
Phuong L. Mai et al.
CANCER GENETICS (2012)
Adjuvant treatment of HER2-positive breast cancer: winning efforts continue to improve HER2-positive patient outcome long-term
Rachel C. Jankowitz et al.
BREAST CANCER RESEARCH (2012)
Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial
Lynnette Fernandez-Cuesta et al.
BREAST CANCER RESEARCH (2012)
Multiple Primary Cutaneous Melanomas in Li-Fraumeni Syndrome
Clara Curiel-Lewandrowski et al.
ARCHIVES OF DERMATOLOGY (2011)
p53 signaling and autophagy in cancer A revolutionary strategy could be developed for cancer treatment
Xinbing Sui et al.
AUTOPHAGY (2011)
A Comparison of the Efficacy and Safety of Oral and Intravenous Fludarabine in Chronic Lymphocytic Leukemia in the LRF CLL4 Trial
Claire E. Dearden et al.
CANCER (2011)
Gastric cancer in individuals with Li-Fraumeni syndrome
Serena Masciari et al.
GENETICS IN MEDICINE (2011)
Time to first tumor progression as a predictor of efficacy of continued treatment with trastuzumab beyond progression in human epidermal growth factor receptor 2-positive metastatic breast cancer
Mitsuhiro Hayashi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2011)
Identification of a Novel TP53 Cancer Susceptibility Mutation Through Whole-Genome Sequencing of a Patient With Therapy-Related AML
Daniel C. Link et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Which therapy works better in choroid plexus carcinomas?
Su G. Berrak et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Pharmacogenetic and Germline Prognostic Markers of Lung Cancer
Anne M. Horgan et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study
Anita Villani et al.
LANCET ONCOLOGY (2011)
p53 Transactivation and the Impact of Mutations, Cofactors and Small Molecules Using a Simplified Yeast-Based Screening System
Virginia Andreotti et al.
PLOS ONE (2011)
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
Tom Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Imaging of Cancer Predisposition Syndromes in Children
Johanna Monsalve et al.
RADIOGRAPHICS (2011)
Distress in partners of individuals diagnosed with or at high risk of developing tumors due to rare hereditary cancer syndromes
C. R. M. Lammens et al.
PSYCHO-ONCOLOGY (2011)
Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome
Edenir I. Palmero et al.
CURRENT OPINION IN ONCOLOGY (2010)
The history of p53 A perfect example of the drawbacks of scientific paradigms
Thierry Soussi
EMBO REPORTS (2010)
Childhood predictive genetic testing for Li-Fraumeni syndrome
D. G. Evans et al.
FAMILIAL CANCER (2010)
Applications of the human p53 knock-in (Hupki) mouse model for human carcinogen testing
Ahmad Besaratinia et al.
FASEB JOURNAL (2010)
Detailed Haplotype Analysis at the TP53 Locus in p.R337H Mutation Carriers in the Population of Southern Brazil: Evidence for a Founder Effect
Sonia Garritano et al.
HUMAN MUTATION (2010)
TP53 Alterations Determine Clinical Subgroups and Survival of Patients With Choroid Plexus Tumors
Uri Tabori et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Universal Poor Survival in Children With Medulloblastoma Harboring Somatic TP53 Mutations
Uri Tabori et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Genetic Testing in Li-Fraumeni Syndrome: Uptake and Psychosocial Consequences
Chantal R. M. Lammens et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes
Marielle W. G. Ruijs et al.
JOURNAL OF MEDICAL GENETICS (2010)
A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations
J. R. F. Wilson et al.
JOURNAL OF MEDICAL GENETICS (2010)
Recent Advances in the Biology of Heavy-Ion Cancer Therapy
Nobuyuki Hamada et al.
JOURNAL OF RADIATION RESEARCH (2010)
Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer
Ryo Sakai et al.
MOLECULAR CANCER THERAPEUTICS (2010)
2009 Version of the Chompret Criteria for Li Fraumeni Syndrome
Julie Tinat et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations
Kelly D. Gonzalez et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Predictive diagnosis of the cancer prone Li-Fraumeni syndrome by accident: new challenges through whole genome array testing
T. Schwarzbraun et al.
JOURNAL OF MEDICAL GENETICS (2009)
New challenges for informed consent through whole genome array testing
C. Netzer et al.
JOURNAL OF MEDICAL GENETICS (2009)
High frequency of de novo mutations in Li-Fraumeni syndrome
K. D. Gonzalez et al.
JOURNAL OF MEDICAL GENETICS (2009)
The Role of MRI in Breast Cancer Screening
Constance D. Lehman et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening?
Maria Isabel Waddington Achatz et al.
LANCET ONCOLOGY (2009)
PARP1 Expression in Pediatric Central Nervous System Tumors
Valerie N. Barton et al.
PEDIATRIC BLOOD & CANCER (2009)
Li-Fraumeni Syndrome: The Genetics and Treatment Considerations for the Sarcoma and Associated Neoplasms
Brandi Upton et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2009)
Association of the germline TP53 R337H mutation with breast cancer in southern Brazil
Juliana G. Assumpcao et al.
BMC CANCER (2008)
Detection of R337H a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil
Edenir Inez Palmero et al.
CANCER LETTERS (2008)
A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene
Naohiro Izawa et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome
Serena Masciari et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Cancer gene therapy steadily advances
Vicki Brower
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Molecular diagnostics in chronic lymphocytic leukemia - Pathogenetic and clinical implications
Thorsten Zenz et al.
LEUKEMIA & LYMPHOMA (2008)
TP53 status and response to chemotherapy in breast cancer
Philippe Bertheau et al.
PATHOBIOLOGY (2008)
Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome
Adam Shlien et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Psychological functioning in persons considering genetic counseling and testing for Li-Fraumeni syndrome
Susan K. Peterson et al.
PSYCHO-ONCOLOGY (2008)
Ethical and Legal Implications of Cancer Genetic Testing: Do Physicians Have a Duty to Warn Patients' Relatives About Possible Genetic Risks?
Courtney Storm et al.
JOURNAL OF ONCOLOGY PRACTICE (2008)
Molecular basis of the Li-Fraumeni syndrome:: an update from the French LFS families
G. Bougeard et al.
JOURNAL OF MEDICAL GENETICS (2008)
Genetic causes of brain tumors: Neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes
Christopher J. Farrell et al.
NEUROLOGIC CLINICS (2007)
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
Monica Buzzai et al.
CANCER RESEARCH (2007)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography
Debbie Saslow et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome
Uri Tabori et al.
CANCER RESEARCH (2007)
Restoration of p53 function leads to tumour regression in vivo
Andrea Ventura et al.
NATURE (2007)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
Reduced mammographic density with use of a gonadotropin-releasing hormone agonist-based chemoprevention regimen in BRCA1 carriers
Jeffrey N. Weitzel et al.
CLINICAL CANCER RESEARCH (2007)
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families
Maria Isabel Waddington Achatz et al.
CANCER LETTERS (2007)
The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy
Constantine S. Tam et al.
LEUKEMIA & LYMPHOMA (2007)
Modeling the therapeutic efficacy of p53 restoration in tumors
Carla P. Martins et al.
CELL (2006)
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer
M Olivier et al.
CLINICAL CANCER RESEARCH (2006)
Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation
BC Figueiredo et al.
JOURNAL OF MEDICAL GENETICS (2006)
Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome
P Wong et al.
GASTROENTEROLOGY (2006)
Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations
V Krutilkova et al.
EUROPEAN JOURNAL OF CANCER (2005)
Women age ≤35 years with primary breast carcinoma -: Disease features at presentation
AM Gonzalez-Angulo et al.
CANCER (2005)
Prenatal diagnosis in Li-Fraumeni syndrome
S Avigad et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2004)
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition
M Kriege et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Germline p53 mutations in a cohort with childhood sarcoma: Sex differences in cancer risk
SJ Hwang et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome
DGR Evans et al.
JOURNAL OF MEDICAL GENETICS (2002)
Mutant p53-dependent growth suppression distinguishes PRIMA-1 from known anticancer drugs: a statistical analysis of information in the National Cancer Institute database
VJN Bykov et al.
CARCINOGENESIS (2002)
Heritability of mammographic density, a risk factor for breast cancer
NF Boyd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Results of first salvage therapy for patients refractory to a fluidarabine regimen in chronic lymphocytic leukemia
MJ Keating et al.
LEUKEMIA & LYMPHOMA (2002)
Characterization of the p53-rescue drug CP-31398 in vitro and in living cells
TM Rippin et al.
ONCOGENE (2002)
An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors
AC Latronico et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
A inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma
RC Ribeiro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Sensitivity and predictive value of criteria for p53 germline mutation screening
A Chompret et al.
JOURNAL OF MEDICAL GENETICS (2001)
分享论文
